Portage Biotech
PRTG
#10231
Rank
S$20.02 M
Marketcap
Country
S$8.79
Share price
-2.16%
Change (1 day)
71.80%
Change (1 year)

Earnings for Portage Biotech (PRTG)

Earnings in 2024 (TTM): -S$0.11 Billion

According to Portage Biotech's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$0.22 Billion a decrease over its 2022 earnings that were of -S$22.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Portage Biotech from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.11 Billion-52.37%
2023 -S$0.22 Billion891.76%
2022 -S$22.03 Million-18.44%
2021 -S$27.01 Million348.58%
2020 -S$6.03 Million-39.96%
2019 -S$10.03 Million-106.26%
2018 S$0.16 B-621.51%
2017 -S$30.73 Million-213.76%
2016 S$27.01 M-336.72%
2015 -S$11.42 Million81.72%
2014 -S$6.28 Million-4.91%
2013 -S$6.61 Million
2007 -S$0.02 Million-101.23%
2006 S$1.18 M-116.89%
2005 -S$7.02 Million264.28%
2004 -S$1.93 Million650.8%
2003 -S$0.26 Million-54.15%
2002 -S$0.56 Million11.37%
2001 -S$0.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NRC Health
NRC
S$35.59 M-135.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-S$2.79 Million-97.24% Bahamas